<DOC>
	<DOCNO>NCT03104114</DOCNO>
	<brief_summary>Boston Medical Center provide care cancer patient oral cancer medication use Boston Medical Center Specialty Pharmacy ( BMC SP ) . The use oral medication cancer treatment relatively new unfortunately , little known adherence cancer patient . This study evaluate influence pharmacist-driven medication management program adherence persistence rate . Boston Medical Center 's Specialty Pharmacy Adherence Program ( B-SPAP ) , utilize high-touch counseling model involve clinical pharmacist focus educate patient oral cancer treatment . The program require face-to-face counseling pharmacist , use proven patient teach tool , prior initiate treatment oral oncolytic treatment , periodically thereafter , base protocol . This study help improve understanding role pharmacist cancer patient . In addition , study help identify independent factor may contribute impact adherence . The outcomes program compare historical control group patient already receive treatment cancer BMC Specialty Pharmacy .</brief_summary>
	<brief_title>Pharmacist-led Intervention Adherence Patients Undergoing Treatment With Oral Oncology Medication</brief_title>
	<detailed_description />
	<criteria>Pharmacistintervention group 1 . Treatment 1 oral oncology agent . Oral oncology agent define medication take mouth purpose treat patient 's cancer 2 . Treatment dispense BMC Specialty Pharmacy 3 . Age &gt; 18 year 4 . Life expectancy &gt; 6 month 5 . Patients must ability give write consent , , must legally authorize representative 1 . Treatment indicate neoadjuvant , adjuvant , perioperative treatment 2 . Concurrent radiation treatment 3 . Patients unable oral oncology agent dispense BMC Specialty Pharmacy Historical Control : 1 . 2 controls:1 intervention match 2 . Matched patient intervention group base drug type</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>